HER2 Cancer Test
Links shared publicly online about this topic
Breast Cancer - HER2 Test Approved | ThirdAge
thirdage.com — “A new genetic test that helps breast cancer patients determine if they are good candidates for treatment with the drug Herceptin was approved Tuesday by the U.S. Food and Drug Administration.” View full resource at thirdage.com
Most Recently Shared on June 15, 2011 at 4:22 pm By:
Breast Cancer - HER2 Test Approved http://bit.ly/lgX2L0
Inform Dual ISH HER2 Test Approved for Breast Cancer - ONA
oncologynurseadvisor.com — “The FDA has approved Inform Dual ISH from Ventana Medical Systems, a genetic test to help determine if women with breast cancer are HER2-positive and therefore candidates to receive Herceptin (trastuzumab; Genentech), a HER2 inhibitor.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 14, 2011 at 9:32 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Inform Dual ISH HER2 Test Approved for Breast Cancer http://goo.gl/fb/GHqur
Examining the HER2 Testing Puzzle: Fresh Research Explores Nagging Questions
onclive.com — “HER2 status in patients with breast cancer has emerged as a durable and effective marker for evaluating tumors and selecting therapies.” View full resource at onclive.com
Most Recently Shared on March 27, 2012 at 3:40 pm By:
Examining the HER2 Testing Puzzle: Fresh Research Explores Nagging Questions http://t.co/tmydog6N
FDA Approves Test That Spots HER2-Positive Breast Cancers - Drugs.com MedNews
drugs.com — “A new genetic test that helps determine if breast cancer patients are good candidates for treatment with the drug Herceptin was approved Tuesday by the U.S. Foo” View full resource at drugs.com
Most Recently Shared on June 14, 2011 at 7:16 pm By:
Drugs and Devices OW OW Health
FDA Approves Test That Spots HER2-Positive Breast Cancers: TUESDAY, June 14 -- A new genetic test that hel... http://bit.ly/jrwVH4 #drug
New Genetic Test Aids Detection of HER2+ Breast Cancer
onclive.com — “On Tuesday the FDA approved a genetic test known as Inform Dual ISH that detects HER2+ breast cancer” View full resource at onclive.com
Most Recently Shared on June 15, 2011 at 4:48 pm By:
FDA Approves a New Genetic Test for the Detection of HER2+ Breast Cancer http://t.co/2HCQ9Tf
FDA Approves Test for HER2 Gene in Breast Cancer Tissue : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on June 14, 2011 at 8:58 pm By:
Miriam E. Tucker Patient Expert
RT @IntMedNews: FDA Approves Test for HER2 Gene in Breast Cancer Tissue http://bit.ly/kV9yd8
Medical News: FDA Clears Improved HER2 Test in Breast Cancer - in Oncology/Hematology, Breast Cancer from MedPage Today
medpagetoday.com — “The FDA has approved a new quantitative test for HER2 genes in breast tumor samples that can be performed under a standard microscope, potentially making it easier to identify patients who would benef” View full resource at medpagetoday.com
Most Recently Shared on June 15, 2011 at 1:25 pm By:
FDA Clears Improved HER2 Test in Breast Cancer http://bit.ly/loaX1B
Exploring HER2 In Breast Cancer Treatment Responsiveness
medicalnewstoday.com — “Research from The Cancer Institute of New Jersey (CINJ) on biological pathways that govern progression and treatment responsiveness of HER2 positive breast cancer is being presented at the 102nd A” View full resource at medicalnewstoday.com
Most Recently Shared on April 5, 2011 at 8:05 pm By:
Exploring HER2 In Breast Cancer Treatment Responsiveness http://mnt.to/3Tdc #breastcancer
SABCS: HER2 Test Inaccuracies Found Even at Expert Labs (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “SAN ANTONIO (MedPage Today) -- Women should get a second opinion when breast cancer test results come back HER2 negative, researchers suggested.” View full resource at qualitypointtech.net
Most Recently Shared on December 14, 2010 at 8:48 pm By:
SABCS: HER2 Test Inaccuracies Found Even at Expert Labs (CME/CE): SAN ANTONIO (MedPage Today) -- Women should get ... http://bit.ly/fLyMHf
Biocept and Clarient Announce Collaboration on First Test for Circulating Tumor Cells and HER2 Status in Breast Cancer Patients | Biomarker Commons
biomarkercommons.org — “Biocept, Inc., a privately-held CLIA-certified laboratory testing company, focused on the detection and analysis of circulating tumor cells (CTCs) in cancer patients, and Clarient, Inc.” View full resource at biomarkercommons.org
Most Recently Shared on August 25, 2011 at 4:47 pm By:
Medical News: SABCS: HER2 Test Inaccuracies Found Even at Expert Labs - in Meeting Coverage, SABCS from MedPage Today
medpagetoday.com — “SAN ANTONIO -- Women should get a second opinion when breast cancer test results come back HER2 negative, researchers suggested.” View full resource at medpagetoday.com
Most Recently Shared on December 14, 2010 at 9:11 pm By:
SABCS: HER2 Test Inaccuracies Found Even at Expert Labs (CME/CE): SAN ANTONIO (MedPage Today… http://goo.gl/fb/wUKVp
Vaccine against HER2-positive breast cancer offers complete protection in lab
eurekalert.org — “Researchers at Wayne State University have tested a breast cancer vaccine they say completely eliminated HER2-positive tumors in mice -- even cancers resistant to current anti-HER2 therapy --- without any toxicity.” View full resource at eurekalert.org
Most Recently Shared on September 15, 2008 at 4:34 am By:
AAAS Vaccine against HER2-positive breast cancer offers complete protection in lab http://tinyurl.com/6dtu7c
Exploring HER2 in Breast Cancer Treatment Responsiveness
newswise.com — “Research from New Jersey--™s only NCI-Comprehensive Cancer Center explores the protein HER2 and the role it plays in breast cancer aggressiveness, poor clinical outcome and chemotherapy resistance. The findings, being presented at the 102 Annual Meeting of the AACR, indicate that under stressful conditions, too much HER2 can cause a decrease in the cell-survival mechanism of autophagy. This decrease can lead to the alteration of other cellular processes and may increase breast cancer metas” View full resource at newswise.com
Most Recently Shared on April 5, 2011 at 5:46 pm By:
#health news: Exploring HER2 in Breast Cancer Treatment Responsiveness: Research from New Jersey's only NCI-Comp... http://bit.ly/fscAGN
Drugs for HER-2-positive Breast Cancer
springer.com — “Drugs for HER-2-positive Breast Cancer - Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best ...” View full resource at springer.com
Most Recently Shared on January 9, 2011 at 5:21 pm By:
Drugs and Devices OW OW Health
Drugs for HER-2-positive Breast Cancer: series:Milestones in Drug TherapyGrowth factor receptors have long been ... http://bit.ly/fYhvU8
Breast Cancer and HER2: eMedicine Genomic Medicine
emedicine.medscape.com — “Overview: Approximately 30% of malignant breast cancers demonstrate overamplification of the human epidermal receptor type 2 (HER2) gene, resulting in an overexpression of the HER2 receptor, a transmembrane tyrosine kinase receptor within the epidermal growth factor receptor ...” View full resource at emedicine.medscape.com
Most Recently Shared on June 2, 2010 at 7:27 pm By:
About 30% of malignant breast cancers demonstrate overamplification of the HER2 gene. http://bit.ly/bXI1EO
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
ThirdAge.com
A boomer's guide to a life of health, happiness, passion & purpose.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
Editor
Editors of Oncology & Biotech News/Oncology Net Guide/OncNurse/Contemporary Oncology, on cancer news from pharma, trials, technology, & more.
Advertisement
